Trial NCT00784693

View at ClinicalTrials.gov 
Org. Study IDs: A4091023
Secondary IDs: ENDOMETRIOSIS POC

Last trial update was posted on 2021-04-30

MeSH Interventions

Tanezumab

MeSH Conditions

Endometriosis

Other Conditions


Stopping Reasons

Further recruitment into the study was ceased on 10th December 2009, not attributed to safety. All patients recruited in the study completed all study visits.

Limitations And Caveats

Nerve growth factor (NGF) results were reported only for plasma since a reliable assay was not available for analyzing NGF in urine. Study was prematurely terminated and recruitment was stopped due to futility shown in pre-planned interim analysis.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID